Interventions Targeting Impaired Glucose Tolerance

ReachMD Healthcare Image

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details

Presenters

Comments

Overview
The ACT NOW study examined whether treatment of impaired glucose tolerance in pre-diabetic patients with pioglitazone could prevent or delay the development of type 2 diabetes. Join host Dr. Steven Edelman and his guest, endocrinologist and professor of medicine at the University of California San Diego, Dr. Robert Henry, as they discuss the results and implications for clinical care.

Robert Henry, MD

Robert Henry, MD

Steven Edelman, MD

Steven Edelman, MD

Recommended

Details

Presenters

Comments

Overview
The ACT NOW study examined whether treatment of impaired glucose tolerance in pre-diabetic patients with pioglitazone could prevent or delay the development of type 2 diabetes. Join host Dr. Steven Edelman and his guest, endocrinologist and professor of medicine at the University of California San Diego, Dr. Robert Henry, as they discuss the results and implications for clinical care.

Robert Henry, MD

Robert Henry, MD

Steven Edelman, MD

Steven Edelman, MD

Program Chapters

Segment Chapters

Playlist:

Recommended